Eiger BioPharmaceuticals, Inc. (EIGR) Social Stream



Eiger BioPharmaceuticals, Inc. (EIGR): $6.40

0.10 (+1.59%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add EIGR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 399

in industry

Featured Post From StockTwits About EIGR

$EIGR Steven Kirsch (COVID-19 Early Treatment Fund) has an idea.

“Currently, the five most effective drugs for COVID are:
Interferon lambda
Fluvoxamine or Fluoxetine (Prozac)
Ivermectin
Inhaled budesonide
Camostat
That list was made on July 26, 2021. It will be 4 months before the rest of the world figures it out.”

“Interferon Lambda: If you can get a single injection of Interferon Lambda (made by Eiger), that is the drug with the largest effect size and best safety profile. It is currently only available in clinical trials. It should be taken ASAP after infection for best results. It drastically reduces d-dimer which is an excellent indication that has a dramatic effect in lowering blood clotting (and likely inflammation). You basically will not get hospitalized if you get this drug. If you only can take one drug, this is the drug to take. If you can get access to this drug early, everything else is optional.”

https://www.skirsch.io/how-to-treat-covid/amp/?__twitter_impression=true
Michall, published August 16, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3994 seconds.